Regenerating Heart Using a Novel Compound and Human Wharton Jelly Mesenchymal Stem Cells Publisher Pubmed



Rabbani S¹ ; Soleimani M² ; Imani M³ ; Sahebjam M¹ ; Ghiaseddin A⁴ ; Nassiri SM⁵ ; Majd Ardakani J¹ ; Tajik Rostami M¹ ; Jalali A¹ ; Mousanassab B¹ ; Kheradmandi M⁴ ; Ahmadi Tafti SH¹ Show Affiliations
Source: Archives of Medical Research Published:2017

Abstract

Background Myocardial infarction is a major problem in health system and most conventional therapy is not led to restoration of the health. Stem cell therapy is a method to regenerate the heart but today appropriate cell source and scaffold selection as extracellular matrix to achieve the best effect is disputing. Aim of the Study In this study a combination of human Wharton jelly mesenchymal stem cells (HWJMSCs) with a novel compound consisting polyethylene glycol (PEG), hyaluronic acid and chitosan is presented to heart regeneration. Methods After proliferation and expansion of HWJMSCs, these cells were mixed with scaffold and injected into the infarcted rabbit myocardium. After two months cardiac function and infarcted area were evaluated. Immunohistochemistry performed for vessel count and demonstrating of differentiation ability into cardiomyocytes. To confirm this ability PCR was done. Scanning electron microscope was used to evaluate angiogenesis. Results Improving cardiac function was higher in cell/scaffold group than the others and it was confirmed by SPECT results which showed least defect size in the myocardium. There were a lot of neoangiogenesis in the target group and also cardiomyogenesis observed in cell/scaffold group. PCR results confirmed the presence of differentiated cardiomyocytes and SEM showed well developed vessel in this group. Conclusions Comparing macroscopic and microscopic results between all groups revealed that HWJMSC in combination with this scaffold led to brilliant results regarding cardiac function, angiogenesis and cardiogenesis. It is recommended using these cells and materials for cardiac tissue engineering and regeneration therapy. © 2017 IMSS